These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
705 related items for PubMed ID: 27011213
1. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache. Pihut M, Ferendiuk E, Szewczyk M, Kasprzyk K, Wieckiewicz M. J Headache Pain; 2016; 17():29. PubMed ID: 27011213 [Abstract] [Full Text] [Related]
2. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953 [Abstract] [Full Text] [Related]
3. Treatment of temporomandibular disorders with botulinum toxin. Schwartz M, Freund B. Clin J Pain; 2002 Aug; 18(6 Suppl):S198-203. PubMed ID: 12569969 [Abstract] [Full Text] [Related]
4. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272 [Abstract] [Full Text] [Related]
5. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A. Freund BJ, Schwartz M. Headache; 2002 Apr; 42(10):1033-7. PubMed ID: 12453036 [Abstract] [Full Text] [Related]
6. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Sidebottom AJ, Patel AA, Amin J. Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559 [Abstract] [Full Text] [Related]
7. Measurement of occlusal forces in the therapy of functional disorders with the use of botulinum toxin type A. Pihut M, Wisniewska G, Majewski P, Gronkiewicz K, Majewski S. J Physiol Pharmacol; 2009 Dec; 60 Suppl 8():113-6. PubMed ID: 20400803 [Abstract] [Full Text] [Related]
8. Evaluation of articular disc loading in the temporomandibular joints after prosthetic and pharmacological treatment in model studies. Pihut ME, Margielewicz J, Kijak E, Wiśniewska G. Adv Clin Exp Med; 2017 Dec; 26(3):455-460. PubMed ID: 28791820 [Abstract] [Full Text] [Related]
9. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique. Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D. Cranio; 2012 Apr; 30(2):95-102. PubMed ID: 22606852 [Abstract] [Full Text] [Related]
10. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain. Ivask O, Leibur E, Akermann S, Tamme T, Voog-Oras Ü. Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577 [Abstract] [Full Text] [Related]
11. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Headache; 2001 Oct; 41(7):658-64. PubMed ID: 11554953 [Abstract] [Full Text] [Related]
12. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Headache; 2000 Apr; 40(4):300-5. PubMed ID: 10759934 [Abstract] [Full Text] [Related]
13. The use of botulinum toxin for the treatment of temporomandibular disorder. Freund B, Schwartz M. Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334 [No Abstract] [Full Text] [Related]
14. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Kim JH, Shin JH, Kim ST, Kim CY. Plast Reconstr Surg; 2007 Feb; 119(2):711-7. PubMed ID: 17230111 [Abstract] [Full Text] [Related]
15. Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations. Freund BJ, Schwartz M. Br J Oral Maxillofac Surg; 2003 Oct; 41(5):351-2. PubMed ID: 14581034 [No Abstract] [Full Text] [Related]
16. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Blumenfeld A. Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806 [Abstract] [Full Text] [Related]
17. Changes in masticatory function after injection of botulinum toxin type A to masticatory muscles. Park HU, Kim BI, Kang SM, Kim ST, Choi JH, Ahn HJ. J Oral Rehabil; 2013 Dec; 40(12):916-22. PubMed ID: 24237358 [Abstract] [Full Text] [Related]
18. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series. Baker JS, Nolan PJ. J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397 [Abstract] [Full Text] [Related]
19. Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches? Rollnik JD, Karst M, Fink M, Dengler R. Headache; 2001 Jan; 41(10):985-9. PubMed ID: 11903527 [Abstract] [Full Text] [Related]
20. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain? Thomas NJ, Aronovich S. J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]